We studied 100 healthy women undergoing outpatient gynaecological laparoscopy in a randomized, double-blind and placebo-controlled study to evaluate the effect of neostigmine on postoperative nausea and vomiting (PONV). After induction of anaesthesia with propofol, anaesthesia was maintained with sevoflurane and 66% nitrous oxide in oxygen. Mivacurium was used for neuromuscular block. At the end of anaesthesia, neostigmine 2.0 mg and glycopyrrolate 0.4 mg, or saline, was given i.v. The incidence of PONV was evaluated in the postanaesthesia care unit, on the ward and at home. The severity of nausea and vomiting, worst pain, antiemetic and analgesic use, times to urinary voiding and home readiness were recorded. During the first 24 h after operation, 44% of patients in the neostigmine group and 43% in the saline group did not have PONV. We conclude that neostigmine with glycopyrrolate did not increase the occurrence of PONV in this patient group. (Br.
Postoperative nausea and vomiting (PONV) are common in patients undergoing gynaecological laparoscopic surgery. 1 In outpatient anaesthesia, rapid emergence and low incidence of side effects are necessary to ensure early discharge. 2 A combination of propofol and sevoflurane is usually associated with fast recovery, 3 although a high incidence of PONV still remains.
Mivacurium is a short-acting non-depolarizing neuromuscular blocking agent which is hydrolysed by plasma cholinesterase and can thus be used without reversal. 4 Recovery after a mivacurium infusion can also be accelerated by neostigmine with a dose of at least 20 g kg
91
. 5 The effect of reversal drugs on PONV has been studied in inpatients, 6 7 outpatients 8 9 and children. 10 The results are controversial. We studied patients undergoing outpatient gynaecological laparoscopic surgery, and tested the hypothesis that administration of neostigmine to patients at the end of propofol-sevoflurane-nitrous oxide anaesthesia increases PONV, compared with patients without antagonism of mivacurium block.
Patients and methods
After obtaining approval from the local Ethics Committee of Helsinki University Central Hospital and informed patient consent, we studied 100 healthy women undergoing outpatient gynaecological diagnostic or operative laparoscopy (tubal ligations excluded), in a randomized, double-blind, placebo-controlled study. Other exclusion criteria were obesity (body mass index 927 kg m
92
) and known allergy to ketoprofen. Calculation of sample size was based on our previous study with a similar patient population.
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Patients were premedicated with diazepam 5 mg orally 30-60 min before surgery. Before induction of anaesthesia, infusion of Ringer's acetate was started, and patients received glycopyrrolate 0.2 mg and fentanyl 0.1 mg i.v. Anaesthesia was induced with propofol 2-2.5 mg kg 91 and mivacurium 0.2 mg kg 91 i.v. When needed, patients were given mivacurium either as boluses or as a continuous infusion with a syringe pump to maintain neuromuscular block (less than two twitches in the train-of-four (TOF)). Anaesthesia was maintained with 1.0-1.3 MAC of sevoflurane and 66% nitrous oxide in oxygen. Routine anaesthesia monitoring was used (AS/3, Datex, Helsinki, Finland). When heart rate or arterial pressure values, or both, increased to more than 20% of preanaesthetic values and end-tidal sevoflurane was already adjusted at 1.3 MAC, patients received a bolus dose of alfentanil 0.5 mg. After surgery, sevoflurane was discontinued before nitrous oxide. The time when nitrous oxide was discontinued was considered the end of anaesthesia. Before this, ketoprofen 100 mg i.v. was given. At the end of anaesthesia, when four twitches of TOF were visible with fade, participants were allocated randomly to the study (neostigmine) or control (saline) group (n:50 in each group). Patients in the study group were given neostigmine 2.0 mg and glycopyrrolate 0.4 mg in a volume of 6 ml. Patients in the control group received 6 ml of saline i.v. For pain relief, when needed, patients were given fentanyl 0.05 mg i.v. or ketoprofen 100 mg as a slow i.v. infusion or rectally (maximum dose 300 mg in 24 h). Postoperative antiemetic medication was given for symptoms of prolonged nausea or vomiting according to a strict protocol in the postanaesthesia care unit (PACU): droperidol 0.1 mg/10 kg i.v. was given twice, followed by ondansetron 4 mg i.v. twice. For patients whose i.v. cannula was already discontinued in the ward, metoclopramide 10 mg rectally was given. Antiemetics were administered to patients on the ward according to clinical judgment.
Postoperative nausea and vomiting (PONV) were estimated as in our previous studies 12 13 on a scale of 0-3 (0:no nausea, 1:mild nausea, duration :15 min, 2:prolonged nausea 915 min, 3:retching or vomiting) at awakening and 30, 60 and 90 min after anaesthesia in the PACU. If the patient had both nausea and vomiting, she was recorded only once as having vomited. The visual analogue scale (VAS; 0-10 cm) for patient satisfaction was used on the ward and during the first 24 h at home. The worst pain in the PACU, on the ward and at home was recorded using a four-point scale (none/mild/moderate/severe). An anaesthetist interviewed the patient before discharge and gave her a questionnaire to record pain and PONV symptoms (0-3 scale) during the first 24 h at home. In the PACU, the patient was not allowed to drink, whereas on the ward she was encouraged to drink and ambulate. Home readiness was defined using standard criteria 14 such as the time after the end of anaesthesia when the patient was able to walk, take oral fluids, void and 30 min had passed after the last administration of opioid or antiemetic.
Statistical analysis was performed using the unpaired t test, chi-square test and the MannWhitney U test, where appropriate. Power analyses were calculated by a commonly available public domain program. For all other analyses SPSS for Windows statistical package was used. P:0.05 was considered significant.
Results
We recruited 100 patients (table 1), but two patients in the saline group were excluded from analysis; laparoscopy in one patient was converted to laparotomy, and collection of data for the other was incomplete. Follow-up questionnaires were returned by 86% of patients. Perioperative data are shown in table 2. Alfentanil bolus doses were administered during anaesthesia to 38% of patients in the neostigmine group and to 42% in the saline group. A drain in the peritoneal cavity was inserted in 34% and 29% of patients, respectively.
The incidence of PONV is shown in table 3. There were no differences in the incidence or severity of PONV, or in administration of antiemetics in the PACU or on the ward (table 4) . There were no differences in VAS patient satisfaction scores between the groups at any measurement times.
There was no difference in times to urinary voiding or home readiness between the groups. Voiding was achieved after a median time of 287 (interquartile range 104) min in the neostigmine group (n:43) and 244 (107) min in the saline group (n:42). Home readiness was achieved after 292 (127) min and 249 (130) min in the neostigmine and saline groups, respectively.
Four patients (8%) in the neostigmine group and five (10%) in the saline group were admitted to hospital because of complications related to anaesthesia (PONV, dizziness, pain).
There were no significant differences in fentanyl administration in the PACU or on the ward (table 4.) Distribution of worst pain experienced in the PACU, 
Discussion
Neostigmine and glycopyrrolate for antagonism of neuromuscular block did not increase the incidence of PONV either during the first 90 min after anaesthesia or afterwards. Nausea or vomiting were uncommon in the PACU (seven patients in the neostigmine group and eight in the saline group). Three of the seven patients in the neostigmine group and seven of the eight patients in the saline group still had symptoms on the ward. In this study, fewer patients had PONV than in a previous sevoflurane study by Eriksson, Haasio and Korttila, 11 where patients undergoing gynaecological laparoscopy were evaluated. We did not encourage patients to drink until on the ward and this may explain the difference. Not drinking before discharge after day-case surgery may reduce PONV. 15 On the ward, where patients drank, ate and ambulated, the incidence of PONV was 38% in the neostigmine group and 50% in the saline group.
Our dose of neostigmine (2 mg) was based on the low intensity of neuromuscular block at the time of antagonism (four of four TOF twitches visible with fade), for which 25 g kg 91 is the recommended dose. 16 The dose of neostigmine (33 g kg
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) was also clinically relevant; neostigmine 20 and 40 g kg 91 after mivacurium infusion combined with propofol anaesthesia has been shown to accelerate recovery of neuromuscular block.
Unplanned hospital admission rate in this study was high (17 of 98 patients) but only nine were admitted to hospital for anaesthetic indications. The explanation may relate to our public health care system. The first overnight stay in hospital does not incur any extra cost for the patient and approximately 30% had a drain in the peritoneal cavity. There were no differences between groups in times to home readiness.
The effect of reversal drugs for neuromuscular block on the occurrence of PONV is not clear, although several studies have been published. In common with previous investigators, we used an anticholinergic drug (glycopyrrolate) with neostigmine to prevent bradycardia. King and colleagues 6 studied elderly patients undergoing orthopaedic surgery. They found that reversal drugs increased the incidence of PONV, but they did not follow the symptoms of their patients. Instead, they interviewed patients and nurses 24 h after surgery. Also, Ding, Fredman and White suggested an increase in PONV in an outpatient population after administration of neostigmine and glycopyrrolate. 9 Their anaesthetic method did not include propofol, and morphine was used to relieve pain. Furthermore, it has been suggested that their observations did not allow definite conclusions to be drawn. 17 Therefore, any comparisons between our results and those of Ding, Fredman and White are difficult. Watcha and colleagues 10 studied the incidence of vomiting in 8-9-yr-old children after halothane anaesthesia. They found that the neostigmine-glycopyrrolate combination was associated with more vomiting in the PACU compared with controls. Unfortunately, nausea was not evaluated. Thus their study design differs from ours. The results of Boeke and colleagues, 8 and our previous report 7 are in agreement with our study. Boeke and colleagues used a smaller dose of neostigmine (1.5 mg) and atropine for antagonism of neuromuscular block in the outpatient setting. In our previous study 7 with women undergoing abdominal hysterectomy, there was no difference between those who received 2 mg of neostigmine with glycopyrrolate and those who received an equal volume of saline.
The mechanisms of PONV are multifactorial, and in the investigation of PONV background factors and factors related to the operation, anaesthesia must be well controlled. 18 Also, assessment of nausea and vomiting should be defined. We used an exact protocol to define the symptoms. Administration of effective antiemetics was predetermined before the study. Furthermore, patients were monitored with frequent interviews.
In our study, patients who had received neostigmine had less pain at home than patients who had received saline. Recently, there has been an increased interest in the role of acetylcholine receptors in pain. 19 20 Furthermore, additional studies are warranted to evaluate whether neostigmine decreases postoperative pain.
We determined the size of the study groups based on our earlier sevoflurane study which demonstrated a high incidence of PONV after sevoflurane. 11 Thus according to power analysis, less than 50 patients were needed in each group to resolve a clinically relevant difference. However, the incidence of PONV was much higher in the previous study than in the present one. At this point, repeated power analysis using the present data showed that several hundred patients in each group would be needed to confirm an 80% chance of finding a 20% difference between groups. Therefore, we conclude that no major effect of reversal drugs on PONV was demonstrated in this study. A larger sample size would be needed to study small differences.
In summary, when using propofol and sevoflurane, we found a low incidence of postoperative nausea or vomiting in this high-risk population, consisting of women undergoing gynaecological laparoscopy. The use of neostigmine with glycopyrrolate did not increase the incidence of PONV.
